Daniel S Kapp

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Incidental testicular irradiation from prostate IMRT: it all adds up
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 77:484-9. 2010
  2. pmc Prognostic discrimination of subgrouping node-positive endometrioid uterine cancer: location vs nodal extent
    D S Kapp
    Department of Radiation Oncology, Stanford University School of Medicine, Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305, USA
    Br J Cancer 105:1137-43. 2011
  3. doi request reprint Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy
    Daniel S Kapp
    Division of Radiation Therapy, Department of Radiation Oncology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, California 94305 5847, USA
    Cancer 112:820-30. 2008
  4. ncbi request reprint The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma
    Chad A Hamilton
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Gynecol Oncol 103:679-83. 2006
  5. doi request reprint Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy
    Jose G Bazan
    Department of Radiation Oncology, Stanford University, Stanford, California
    Int J Radiat Oncol Biol Phys 87:983-91. 2013
  6. ncbi request reprint Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients
    John K Chan
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, California 94305, USA
    Cancer 107:1823-30. 2006
  7. doi request reprint Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults
    Phuoc T Tran
    Department of Radiation Oncology, Stanford Cancer Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 72:1146-53. 2008
  8. ncbi request reprint Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women
    Mallory Zhang
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, 875 Blake Wilbur Drive, MC 5827, Stanford, CA 94305, USA
    Gynecol Oncol 104:396-400. 2007
  9. doi request reprint Orthovoltage intraoperative radiotherapy for locally advanced and recurrent colorectal cancer
    Megan E Daly
    Department of Radiation Oncology, University of California Davis, Sacramento, California 95817, USA
    Dis Colon Rectum 55:695-702. 2012
  10. ncbi request reprint The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma
    Anand Parthasarathy
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, 875 Blake Wilbur Drive, MC 5827, Stanford, CA 94305, USA
    Gynecol Oncol 103:1095-9. 2006

Collaborators

Detail Information

Publications50

  1. doi request reprint Incidental testicular irradiation from prostate IMRT: it all adds up
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 77:484-9. 2010
    ..To identify the technical aspects of image-guided intensity-modulated radiation therapy (IMRT) for localized prostate cancer that could result in a clinically meaningful incidental dose to the testes...
  2. pmc Prognostic discrimination of subgrouping node-positive endometrioid uterine cancer: location vs nodal extent
    D S Kapp
    Department of Radiation Oncology, Stanford University School of Medicine, Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305, USA
    Br J Cancer 105:1137-43. 2011
    ..We have investigated the discriminatory ability of subgrouping patients with retroperitoneal nodal involvement based on location, number, and ratio of positive nodes...
  3. doi request reprint Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy
    Daniel S Kapp
    Division of Radiation Therapy, Department of Radiation Oncology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, California 94305 5847, USA
    Cancer 112:820-30. 2008
    ....
  4. ncbi request reprint The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma
    Chad A Hamilton
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Gynecol Oncol 103:679-83. 2006
    ..To compare the outcomes of stage III and IV uterine papillary serous carcinoma (UPSC) patients treated with platinum-based chemotherapy (PC) versus whole abdominopelvic irradiation (WAPI) after optimal cytoreductive surgery...
  5. doi request reprint Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy
    Jose G Bazan
    Department of Radiation Oncology, Stanford University, Stanford, California
    Int J Radiat Oncol Biol Phys 87:983-91. 2013
    ..To determine how chemotherapy agents affect radiation dose parameters that correlate with acute hematologic toxicity (HT) in patients treated with pelvic intensity modulated radiation therapy (P-IMRT) and concurrent chemotherapy...
  6. ncbi request reprint Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients
    John K Chan
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, California 94305, USA
    Cancer 107:1823-30. 2006
    ..The purpose of the current study was to determine the potential therapeutic role of lymphadenectomy in women with endometrioid corpus cancer...
  7. doi request reprint Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults
    Phuoc T Tran
    Department of Radiation Oncology, Stanford Cancer Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 72:1146-53. 2008
    ..To analyze the outcomes of and identify prognostic factors for patients treated with surgery and intraoperative radiotherapy (IORT) for locally advanced and recurrent soft-tissue sarcoma in adults from a single institution...
  8. ncbi request reprint Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women
    Mallory Zhang
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, 875 Blake Wilbur Drive, MC 5827, Stanford, CA 94305, USA
    Gynecol Oncol 104:396-400. 2007
    ..To evaluate prognostic factors that impact on the survival of women with ovarian sex cord stromal tumors (SCST)...
  9. doi request reprint Orthovoltage intraoperative radiotherapy for locally advanced and recurrent colorectal cancer
    Megan E Daly
    Department of Radiation Oncology, University of California Davis, Sacramento, California 95817, USA
    Dis Colon Rectum 55:695-702. 2012
    ..Locally advanced and recurrent colorectal cancers pose a significant therapeutic challenge. Orthovoltage intraoperative radiotherapy provides one potential means of improving disease control at the time of surgery...
  10. ncbi request reprint The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma
    Anand Parthasarathy
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, 875 Blake Wilbur Drive, MC 5827, Stanford, CA 94305, USA
    Gynecol Oncol 103:1095-9. 2006
    ..To determine if adjuvant radiotherapy improves the survival of women with invasive squamous cell carcinoma of the vulva involving one inguinal node...
  11. doi request reprint Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal
    Jose G Bazan
    Department of Radiation Oncology, Stanford University, Stanford, CA, USA
    Cancer 117:3342-51. 2011
    ....
  12. ncbi request reprint Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 73:1017-22. 2009
    ..Using body mass index (BMI) as a measure of obesity, we tested its role as a risk factor for patients receiving salvage RT after prostatectomy...
  13. ncbi request reprint Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies
    Phuoc T Tran
    Department of Radiation Oncology, Stanford Cancer Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 69:504-11. 2007
    ..To analyze the outcomes of therapy and identify prognostic factors for patients treated with surgery followed by intraoperative radiotherapy (IORT) for gynecologic malignancies at a single institution...
  14. doi request reprint The omentum and omentectomy in epithelial ovarian cancer: a reappraisal: part II--The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer
    Alon Ben Arie
    Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel
    Gynecol Oncol 131:784-90. 2013
    ..This article reviews the literature concerning the role of omentectomy in the staging and treatment of clinically apparent early stage epithelial ovarian cancer...
  15. doi request reprint Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes
    Susan M Hiniker
    Department of Radiation Oncology, Stanford University, Stanford, CA, USA
    Gynecol Oncol 131:380-5. 2013
    ..We evaluated prognostic factors and outcomes for patients with primary vaginal SCCA treated with definitive radiation therapy at a single institution...
  16. doi request reprint Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal
    Jose G Bazan
    Department of Radiation Oncology, Stanford University, Stanford, California 94305 5847, USA
    J Nucl Med 54:27-32. 2013
    ..PET imaging has become a useful diagnostic tool in patients with anal cancer. We evaluated the prognostic value of metabolic tumor volume (MTV) in patients with anal cancer treated with definitive chemoradiotherapy...
  17. doi request reprint Evolving trends in the initial locoregional management of male breast cancer
    Scott V Bratman
    Department of Radiation Oncology, Stanford Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305, USA
    Breast 21:296-302. 2012
    ..However, large international prospective registries and inclusion of men in cooperative group randomized trials will be important to confirm the safety and efficacy of modern treatment modalities for male breast cancer...
  18. pmc Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma
    Pavan Bachireddy
    Department of Radiation Oncology, Stanford Cancer Center, Stanford University, Stanford, CA, USA
    Radiat Oncol 5:105. 2010
    ..To analyze the outcomes of patients from a single institution treated with surgery and orthovoltage intraoperative radiotherapy (IORT) for pancreatic adenocarcinoma...
  19. ncbi request reprint Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation
    Phuoc T Tran
    Department of Radiation Oncology, Stanford Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305, USA
    Gynecol Oncol 105:641-9. 2007
    ..To analyze the results of treatment and identify prognostic factors for primary squamous cell carcinoma (SCCA) of the vagina managed with radiotherapy at a single institution...
  20. ncbi request reprint Intraoperative radiation therapy in recurrent ovarian cancer
    O W Stephanie Yap
    Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Stanford University School of Medicine, Stanford, CA, USA
    Int J Radiat Oncol Biol Phys 63:1114-21. 2005
    ..To evaluate disease outcomes and complications in patients with recurrent ovarian cancer treated with cytoreductive surgery and intraoperative radiation therapy (IORT)...
  21. pmc Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysis
    John K Chan
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA Palo Alto Medical Foundation Research Institute, Palo Alto, California, USA Columbia University School of Medicine, New York, New York, USA California Pacific Medical Center Research Institute, San Francisco, California, USA Division of Gynecologic Oncology, Creighton University School of Medicine, St Joseph s Hospital and Medical Center, Phoenix, Arizona, USA Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA Department of Epidemiology and Biostatistics, School of Public Health, University of Memphis, Memphis, Tennessee, USA
    Oncologist 19:523-7. 2014
    ..In this clinically relevant subset of women with high-risk advanced ovarian cancer with overall survival benefit after bevacizumab, our economic model suggests that the incremental cost of bevacizumab was approximately $170,000. ..
  22. doi request reprint Toward a web-based real-time radiation treatment planning system in a cloud computing environment
    Yong Hum Na
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305 USA
    Phys Med Biol 58:6525-40. 2013
    ..This cloud computing infrastructure has been established for a radiation treatment planning. It substantially improves the speed of inverse planning and makes future on-treatment adaptive re-planning possible. ..
  23. doi request reprint The omentum and omentectomy in epithelial ovarian cancer: a reappraisal. Part I--Omental function and history of omentectomy
    Alon Ben Arie
    Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA Department of Obstetrics and Gynecology Kaplan Medical Center, Rehovot, Israel
    Gynecol Oncol 131:780-3. 2013
    ..This article reviews the literature concerning the function of the omentum and how omentectomy came to be part of the staging and treatment of epithelial ovarian cancer...
  24. doi request reprint The management of small-cell carcinomas of the gynecologic tract
    Joshua G Cohen
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars Sinai Women s Cancer Research Institute, Los Angeles, California, USA
    Curr Opin Oncol 24:572-9. 2012
    ..This review provides a summary of current literature that will help the clinician to correctly diagnose and treat patients with small-cell carcinomas of the cervix, ovary, uterus, vagina, and vulva...
  25. doi request reprint Management of melanomas of the female genital tract
    Valerie E Sugiyama
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, Stanford, CA 94305 5847, USA
    Curr Opin Oncol 20:565-9. 2008
    ....
  26. pmc Applications for oncologic drugs: a descriptive analysis of the oncologic drugs advisory committee reviews
    John K Chan
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA Division of Gynecologic Oncology, Creighton University School of Medicine, St Joseph s Hospital and Medical Center, Phoenix, Arizona, USA Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA Palo Alto Medical Foundation Research Institute, Palo Alto, California, USA
    Oncologist 19:299-304. 2014
    ..S. Food and Drug Administration (FDA) are not approved. It is important to identify the concerns of the Oncologic Drugs Advisory Committee (ODAC) from rejected applications...
  27. doi request reprint Radiotherapy after prostatectomy: is the evidence for dose escalation out there?
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 71:346-50. 2008
    ..To study the effective doses of radiotherapy (RT) after prostatectomy in search for evidence of a dose-response...
  28. ncbi request reprint Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma
    Chad A Hamilton
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 63:839-44. 2005
    ..To determine the efficacy of adjuvant therapy in patients with early-stage uterine papillary serous carcinoma...
  29. doi request reprint Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance
    Renata R Urban
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, CA, USA
    Am J Obstet Gynecol 204:e9-e12. 2011
    ..The management of these patients is presented. Such individuals may not be receiving regular gynecologic care appropriate to their remaining genital organs; symptoms of malignant disease may be missed...
  30. doi request reprint External beam radiation therapy enhances local control in pigmented villonodular synovitis
    Melissa Horoschak
    Department of Radiation Oncology, Stanford Cancer Center, Stanford School of Medicine, Stanford, CA, USA
    Int J Radiat Oncol Biol Phys 75:183-7. 2009
    ..Pigmented villonodular synovitis (PVNS) is a rare proliferative disorder of the synovium with locally aggressive behavior. We reviewed our experience using radiation therapy in the treatment of PVNS...
  31. ncbi request reprint Influence of the gynecologic oncologist on the survival of ovarian cancer patients
    John K Chan
    Division of Gynecologic Oncology, Department of Obstetrics, University of California, San Francisco School of Medicine, San Francisco Comprehensive Cancer Center, San Francisco, California 94143 1702, USA
    Obstet Gynecol 109:1342-50. 2007
    ..To estimate the influence of gynecologic oncologists on the treatment and outcome of patients with ovarian cancer...
  32. ncbi request reprint Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States
    John K Chan
    Division of Gynecologic Oncology, Department of Obsetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
    J Surg Oncol 97:103-7. 2008
    ..To compare the racial differences in treatment and survival of epithelial ovarian cancer patients...
  33. ncbi request reprint Vulvar melanoma: a multivariable analysis of 644 patients
    Valerie E Sugiyama
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco School of Medicine, UCSF Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, USA
    Obstet Gynecol 110:296-301. 2007
    ..To determine the prognostic factors associated with the survival of vulvar melanoma patients...
  34. ncbi request reprint Role of complete lymphadenectomy in endometrioid uterine cancer
    John K Chan
    University of California, San Francisco Comprehensive Cancer Center, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, San Francisco, CA, USA
    Lancet Oncol 8:831-41. 2007
    ..Moreover, we discuss the complications associated with lymphadenectomy and identify subsets of low-risk patients who might not need to undergo this procedure...
  35. ncbi request reprint Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer
    John K Chan
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Comprehensive Cancer Center, 94143 1702, USA
    Gynecol Oncol 108:95-9. 2008
    ..A significant number of young patients with early-stage ovarian cancer did not receive chemotherapy based on standard practice guidelines. We investigated factors associated with the suboptimal treatment in these women...
  36. ncbi request reprint Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients
    John K Chan
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California at San Francisco School of Medicine, University of California, San Francisco Comprehensive Cancer Center, California 94143 1702, USA
    Cancer 109:2454-60. 2007
    ....
  37. ncbi request reprint Prognostic factors for uterine cancer in reproductive-aged women
    Nita Karnik Lee
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California 94143, USA
    Obstet Gynecol 109:655-62. 2007
    ..To determine the prognostic factors that influence the survival of younger women diagnosed with uterine cancer...
  38. doi request reprint Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer
    John K Chan
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Services, University of California, San Francisco School of Medicine, Helen Diller Family Comprehensive Cancer Center, 94143 1702, USA
    Am J Obstet Gynecol 198:216.e1-5. 2008
    ..The purpose of this study was to evaluate the role of surgical staging in patients with grade 1 endometrioid uterine cancer...
  39. doi request reprint Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths
    Stefanie M Ueda
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF, School of Medicine and Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
    Am J Obstet Gynecol 198:218.e1-6. 2008
    ..The purpose of this study was to determine factors responsible for the increasing number of deaths from corpus cancer over three time periods...
  40. ncbi request reprint Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer
    Anand Parthasarathy
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California 94143 1702, USA
    Obstet Gynecol 110:1237-43. 2007
    ..To estimate if adjuvant radiotherapy improves the disease-specific survival of patients with clinical stage IC and II endometrioid corpus cancer who did not undergo lymphadenectomy...
  41. doi request reprint Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study
    John K Chan
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California 94143 1702, USA
    Cancer 112:2202-10. 2008
    ..The purpose was to identify the factors predictive of recurrence and survival in patients with high-risk (stage I, grade 3; stage IC, stage II, or clear cell) epithelial ovarian cancer after adjuvant therapy...
  42. doi request reprint Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
    John K Chan
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
    Gynecol Oncol 109:370-6. 2008
    ..To compare the clinico-pathologic characteristics and survival of women with clear cell versus other epithelial ovarian cancers...
  43. doi request reprint The influence of conservative surgical practices for malignant ovarian germ cell tumors
    John K Chan
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Helen Diller Family, Comprehensive Cancer Center, San Francisco, California 94143 1702, USA
    J Surg Oncol 98:111-6. 2008
    ..To evaluate demographics, survival, and surgical trends for patients with malignant ovarian germ cell tumors...
  44. ncbi request reprint The outcomes of 27,063 women with unstaged endometrioid uterine cancer
    John K Chan
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA 94143, USA
    Gynecol Oncol 106:282-8. 2007
    ..Over two-thirds of patients with endometrioid uterine cancer in the Surveillance, Epidemiology and End Results program from 1988 to 2001 did not undergo a lymphadenectomy. These patients were compared to those who had a lymphadenectomy...
  45. ncbi request reprint Uterine cancers
    Benjamin E Greer
    Fred Hutchinson Cancer Research Center Seattle Cancer Care Alliance, Seattle, WA, USA
    J Natl Compr Canc Netw 4:438-62. 2006
  46. ncbi request reprint Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy
    Karin S Kapp
    Department of Radiation Oncology, Karl Franzens University Medical School, Auenbruggerplatz 32, 8036 Graz, Austria
    Int J Radiat Oncol Biol Phys 54:58-66. 2002
    ..However, the therapeutic benefit of measures to correct the anemia remains controversial. The objective of this study was to determine the impact of routine transfusion in patients with hemoglobin level (hb-l) < or =11 g/dl...
  47. ncbi request reprint Cervical cancer
    Benjamin E Greer
    J Natl Compr Canc Netw 6:14-36. 2008
  48. doi request reprint Clinical aspects of uterine papillary serous carcinoma
    Chad A Hamilton
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Walter Reed Army Medical Center, Washington, District of Columbia, USA
    Curr Opin Obstet Gynecol 20:26-33. 2008
    ..We review the demographic and clinicopathologic characteristics, and prognosis of women diagnosed with uterine papillary serous carcinoma, with a focus on clinical management...
  49. doi request reprint Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success?
    John K Chan
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
    J Clin Oncol 26:1511-8. 2008
    ....
  50. ncbi request reprint Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma
    Karin S Kapp
    Department of Radiation Oncology, Karl Franzens University Medical School Graz, Graz, Austria
    Int J Radiat Oncol Biol Phys 62:1399-404. 2005
    ..To assess whether embolization compromises the radiocurability of primary cervical cancer...